Point of care testing, is a medical testing that is performed outside of a laboratory setting. The implementation of POC testing is helpful for value-based healthcare where there is a need for more convenient diagnosis, accurate monitoring, early detection and the prevention and management of chronic conditions. In this report, we have covered diagnostic markets: Glucose Monitoring Infectious Disease, Pregnancy & Fertility Testing Market, Hermatology Testing, Cardio metabolic Monitoring, Coagulation Monitoring, Urinalysis, and Tumor Markers. According to Renub Research, The Global Point of Care Diagnostics Market will be US$ 44.00 Billion by 2027.
Worldwide Point of Care Diagnostics Market Size was US$ 29.04 Billion in 2021
Around the world, testing devices have been designed for point of care with reduced footprints and ability to analyze a larger range of biomarkers, making them more flexible than machinery in the central laboratory. Portability and versatility have expanded POC testing’s capability; diagnoses are conducted in less traditional places, such as lower-income and under-served populations, rural regions, and areas with limited infrastructure. Furthermore, the factors that drive the global Point of Care diagnostic are the surging prevalence of diseases which demand for better treatment and rapid diagnostic services. Staff shortages in clinical laboratories are primarily driving the demand for POC diagnostics.
Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=point-of-care-diagnostic-market-p.php
United States Point of Care Diagnostics Market has the Lion’s Share
In this report we have covered by Country such as the United States, China, Japan, United Kingdom, Germany, Spain, Italy, Argentina, India, Brazil, Canada, and Mexico. The United States holds the dominant position across countries covered in this report and expected to continue its dominance during forecast period. The factors that contribute to this country's growth are the surging geriatric population base in the country, rising prevalence of diseases, and the favorable government regulations and initiatives undertaken to develop healthcare infrastructure. Emerging countries has been growing continuously and tend to do well during the forecast period as suggested by our analyst.
COVID-19 Impact on Point of Care Diagnostics Industry
Around the world, industries have been impacted by COVID-19 pandemic outbreak due to lockdowns, restrictions, and unavailability of transportation. But point of care diagnostics technologies has grown many folds. With many technologies approved during the pandemic for commercialization in the past 10 months, the field of COVID-19 POC diagnostics is rapidly evolving. As such, worldwide companies are in search of developing these devices to provide a reliable method of virus detection. The point of care market has multiplied during the pandemic and will surge post-recovery as expected. As per our research findings, the global Point of Care Diagnostics Industry will grow at a CAGR of 7.17% during 2021-2027.
Renub Research new report “Global Point of care diagnostic Market by Diagnostic types (Glucose Monitoring Infectious Disease, Pregnancy & Fertility Testing Market, Hermatology Testing, Cardio metabolic Monitoring, Coagulation Monitoring, Urinalysis, and Tumor Markers) Technology (Biosensor, Lateral Flow, Agglutination, Flow Through, Solid phase) End Users (Hospital, Clinics, Diagnostic centers, Others) Country (United States, China, Japan, United Kingdom, Germany, Spain, Italy, Argentina, India, Brazil, Canada, Mexico) Company (Sysmex, Abbott Laboratories (US, Becton Dickinson and Company (US), Danaher Corporation (US),Quidel Diagnostics (US))" provides in-depth analysis on the Point of care global industry.
Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/point-of-care-diagnostic-market-p.php
Diagnostics Types – Market breakup from 8 viewpoints
1. Glucose Monitoring
2. Infectious Disease
3. Pregnancy & Fertility Testing Market
4. Hermatology Testing
5. Cardiometabolic Monitoring
6. Coagulation Monitoring
8. Tumor Markers
Technology - Market breakup from 5 viewpoints
2. Lateral Flow
4. Flow Through
5. Solid phase
End User - Market breakup from 4 viewpoints
3. Diagnostic centers
Country - Market breakup of 12 countries
1. United States
4. United Kingdom
All companies have been covered from 3 viewpoints
• Recent Developments
2. Abbott Laboratories (US)
3. Becton Dickinson and Company (US)
4. Danaher Corporation (US)
5. Quidel Diagnostics (US)
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.
Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)
Email: [email protected]
Follow on Linkedin: https://www.linkedin.com/company/renub-research
Follow on Twitter: @renubresearch